International Conference on Leukemia and Hematologic Oncology October 17-18,2016 Rome Italy

Myelodysplastic–Syndrome

The myelodysplastic syndromes (also known as MDS or myelodysplasia) are haematological medical conditions with ineffective production of all blood cells. In some cases, the disease worsens and the patient develops low blood counts caused by progressive bone marrow failure. The myelodysplastic syndromes are all disorders of the hematopoietic stem cells in the bone marrow. In MDS, blood production is disorderly and ineffective. The number and quality of blood-forming cells decline irreversibly, further impairing blood production. In this section detailed information about myelodysplastic syndromes will be discussed.

• Myelodysplastic Syndrome prognosis
• Types of Myelodyplastic Syndrome
• Risk Factors for Myelodyplastic Syndrome
• Diagnosing Myelodylpastic Syndrome
• Advanced treatment for Myelodysplastic Syndrome